.Merck beats revenues requirements, brings up purchases outlook on solid demand for best drugs like Keytruda CNBCMerck & Co. (MRK United States) Trumps Earnings Estimates as Keytruda Sales Surge BloombergMerck Supply: Pharma Titan Posts Sturdy End Results, Yet Outlook Drops Short Financier's Organization DailyMerck Announces Second-Quarter 2024 Financial Outcomes Yahoo FinanceMerck beats income and also purchases requirements among Keytruda asset, yet supplies combined full-year outlook MarketWatch.